Sign up to save your podcasts
Or
Share Epi 09 - Obstetric Antiphospholipid Syndrome
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Epi 09 - Obstetric Antiphospholipid Syndrome
This issue focuses on Obstetric APS (OAPS), an APS variant affecting pregnancy at various stages and increasingly recognized as separate from its thrombotic counterpart.
Antiphospholipid Syndrome is a rare disease, more frequently diagnosed in women than in men. In the United States, the estimated annual prevalence of OAPS is around 4 cases per 100,000 individuals, with rates rising to 13 per 100,000 among women aged 30 to 39. If left untreated, fetal loss may occur in 30-80% of the pregnancies.
Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content.
We hope you join this effort!
This episode includes AI-generated content.
Antiphospholipid Syndrome is a rare disease, more frequently diagnosed in women than in men. In the United States, the estimated annual prevalence of OAPS is around 4 cases per 100,000 individuals, with rates rising to 13 per 100,000 among women aged 30 to 39. If left untreated, fetal loss may occur in 30-80% of the pregnancies.
Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content.
We hope you join this effort!
This episode includes AI-generated content.
View all episodes
By EEMEAThis issue focuses on Obstetric APS (OAPS), an APS variant affecting pregnancy at various stages and increasingly recognized as separate from its thrombotic counterpart.
Antiphospholipid Syndrome is a rare disease, more frequently diagnosed in women than in men. In the United States, the estimated annual prevalence of OAPS is around 4 cases per 100,000 individuals, with rates rising to 13 per 100,000 among women aged 30 to 39. If left untreated, fetal loss may occur in 30-80% of the pregnancies.
Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content.
We hope you join this effort!
This episode includes AI-generated content.
Antiphospholipid Syndrome is a rare disease, more frequently diagnosed in women than in men. In the United States, the estimated annual prevalence of OAPS is around 4 cases per 100,000 individuals, with rates rising to 13 per 100,000 among women aged 30 to 39. If left untreated, fetal loss may occur in 30-80% of the pregnancies.
Werfen is committed to Powering Patient Care and raising global awareness of thrombosis to enhance patient outcomes.
This library of audio versions is generated using a text-to-speech tool of the monthly articles of the Thrombosis Awareness content.
We hope you join this effort!
This episode includes AI-generated content.